Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

Cited by (538)

Items 101–200 of 538

1. Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm
   Zhen Wang, Lei Xiang, Feng Lin, Zhengwei Cai, Huitong Ruan, Juan Wang, Jing Liang, Fei Wang, Min M. Lu, Wenguo Cui · 2021 · Matter
2. Synergistic Inhibition of SARS-CoV‑2 Replication Using Disulfiram/Ebselen and Remdesivir
   Ting Chen, Cheng‐Yin Fei, Yiping Chen, Karen Sargsyan, Chun‐Ping Chang, Hanna S. Yuan, Carmay Lim · 2021 · ACS Pharmacology & Translational Science
3. A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance
   Lori A. Bourassa, Garrett A. Perchetti, Quynh Phung, Michelle J. Lin, Margaret G. Mills, Pavitra Roychoudhury, Kimberly G. Harmon, Jonathan C. Reed, Alexander L. Greninger · 2021 · Journal of Clinical Virology
4. Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection
   Andreas Heyer, Thomas Günther, Alexis Robitaille, Marc Lütgehetmann, Marylyn M. Addo, Dominik Jarczak, Stefan Kluge, Martin Aepfelbacher, Julian Schulze zur Wiesch, Nicole Fischer et al. · 2022 · Cell Reports Medicine
5. A review on evolution of emerging SARS-CoV-2 variants based on spike glycoprotein
   Nimisha Ghosh, Suman Nandi, Indrajit Saha · 2022 · International Immunopharmacology
6. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
   Hejun Liu, M. Yuan, De-Li Huang, S. Bangaru, Fang-Zhu Zhao, C. D. Lee, Linghang Peng, Shawn Barman, Xue-Yong Zhu, D. Nemazee et al. · 2021 · Cell Host and Microbe
7. Monitoring Emergence of the SARS-CoV-2 B.1.1.7 Variant through the Spanish National SARS-CoV-2 Wastewater Surveillance System (VATar COVID-19)
   Albert Carcereny, Adán Martínez-Velázquez, Albert Bosch, Ana Allende, Pilar Truchado, Jenifer Cascales, Jesús L. Romalde, Marta Lois, David Polo, Glòria Sánchez et al. · 2021 · Environmental Science & Technology
8. A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
   Allison J. Greaney, Tyler N. Starr, Rachel T. Eguia, Andrea N. Loes, Khadija Khan, Farina Karim, Sandile Cele, John E. Bowen, Jennifer K. Logue, Davide Corti et al. · 2022 · PLoS Pathogens
9. The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
   Pedro Filho Noronha Souza, Felipe Pantoja Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny Roger Pereira Lima, Marília Braga Costa, Izabelle Rocha Farias, Mônica O. Belém, Yago O. Pinto, H. H. T. Moreira et al. · 2022 · International Journal of Biological Macromolecules
10. SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives
    Samuel Long · 2021 · Viruses
11. SARS-CoV-2 variants – Evolution, spike protein, and vaccines
    Kai-Wei K. Chen, Daniel Tsung‐Ning Huang, Li‐Min Huang · 2022 · Biomedical Journal
12. SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021
    Mohammad Alkhatib, Valentina Svicher, Romina Salpini, Francesca Alessandra Ambrosio, Maria Concetta Bellocchi, Luca Carioti, Lorenzo Piermatteo, Rossana Scutari, Giosuè Costa, Anna Artese et al. · 2021 · Microbiology Spectrum
13. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile
    Mohammad Alkhatib, Romina Salpini, Luca Carioti, Francesca Alessandra Ambrosio, Stefano D’Anna, Leonardo Duca, Giosuè Costa, Maria Concetta Bellocchi, Lorenzo Piermatteo, Anna Artese et al. · 2022 · Microbiology Spectrum
14. An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo
    Nariko Ikemura, Shunta Taminishi, Tohru Inaba, Takao Arimori, Daisuke Motooka, Kazutaka Katoh, Yuhei Kirita, Yusuke Higuchi, Songling Li, Tatsuya Suzuki et al. · 2022 · Science Translational Medicine
15. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro
    Mary Hongying Cheng, Rebecca A. Porritt, Magali Noval Rivas, James Krieger, Asli Beyza Ozdemir, Gustavo Garcia, Vaithilingaraja Arumugaswami, Bettina C. Fries, Moshe Arditi, İvet Bahar · 2021 · Structure
16. N-terminal domain mutations of the spike protein are structurally implicated in epitope recognition in emerging SARS-CoV-2 strains
    Apostolos Klinakis, Zoe Cournia, Theodoros N Rampias · 2021 · Computational and Structural Biotechnology Journal
17. Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review
    Daniele Focosi, Fabrizio Maggi, Massimo Franchini, Scott A. McConnell, Arturo Casadevall · 2021 · International Journal of Molecular Sciences
18. The ins and outs of SARS-CoV-2 variants of concern (VOCs)
    ‪Mostafa Salehi-Vaziri, Mehdi Fazlalipour, Seyed Mahmood Seyed Khorrami, Kayhan Azadmanesh, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Zabihollah Shoja, Ali Maleki · 2022 · Archives of Virology
19. Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E
    Yue Zhu, Frank Scholle, Samantha C. Kisthardt, De‐Yu Xie · 2022 · Virology
20. SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19
    Oksana V. Stanevich, Evgeniia I. Alekseeva, Maria V. Sergeeva, Artem V. Fadeev, Комиссарова Ксения Сергеевна, Anna A. Ivanova, Tamara Simakova, Kirill Vasilyev, Anna-Polina S. Shurygina, Marina Stukova et al. · 2023 · Nature Communications
21. Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment
    Mary Hongying Cheng, James Krieger, Burak Kaynak, Moshe Arditi, İvet Bahar · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
22. Omicron variant of SARS-CoV-2 harbors a unique insertion mutation of putative viral or human genomic origin
    AJ Venkatakrishnan, Praveen Anand, Patrick J. Lenehan, Rohit Suratekar, Bharathwaj Raghunathan, Michiel J.M. Niesen, Venky Soundararajan · 2021
23. SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
    Shanti Pather, Shabir Ahmed Madhi, Benjamin John Cowling, Paul A. H. Moss, Jeremy P. Kamil, Sandra Ciesek, Alexander Muik, Özlem Türeci · 2023 · Frontiers in Immunology
24. SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity
    Bo Meng, Rawlings P. Datir, Jinwook Choi, Stephen G. Baker, Gordon Dougan, Christoph Hess, Nathalie Kingston, Paul J. Lehner, Paul Lyons, Nicholas J. Matheson et al. · 2022 · Cell Reports
25. The evolutionary dynamics of endemic human coronaviruses
    Wendy Karen Jo, Christian Drosten, Jan Felix Drexler · 2021 · Virus Evolution
26. Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
    Fuxing Lou, Maochen Li, Zehan Pang, Lin Jiang, Lin Guan, Lili Tian, Jiaming Hu, Junfen Fan, Huahao Fan · 2021 · Frontiers in Immunology
27. Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
    Ghady Haidar, John W. Mellors · 2021 · Clinical Infectious Diseases
28. The way of SARS-CoV-2 vaccine development: success and challenges
    Yetian Dong, Tong Dai, Bin Wang, Lei Zhang, Linghui Zeng, Jun Huang, Haiyan Yan, Long Zhang, Fangfang Zhou · 2021 · Signal Transduction and Targeted Therapy
29. Covid-19: virology, variants, and vaccines
    Megan Young, Harry Crook, Janet T. Scott, Paul Edison · 2022 · BMJ Medicine
30. Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City
    Ralf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Guiqing Wang, Jennifer Lighter, Brian D. Elbel, Andrea B. Troxel, Adriana Heguy · 2021 · Journal of Clinical Investigation
31. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil
    Felipe Gomes Naveca, Valdinete Alves do Nascimento, Victor Costa de Souza, André de Lima Guerra Corado, Fernanda Nascimento, George Silva, Matilde Mejía, Maria Júlia Brandão, Ágatha Costa, Débora Duarte et al. · 2022 · Microbiology Spectrum
32. Rapid characterization of spike variants via mammalian cell surface display
    Kamyab Javanmardi, Chia‐Wei Chou, Cynthia I. Terrace, Ankur Annapareddy, Tamer Saad Kaoud, Qingqing Guo, Josh Lutgens, Hayley Zorkic, Andrew P. Horton, Elizabeth C. Gardner et al. · 2021 · Molecular Cell
33. Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas Region of the Philippines
    Tablizo, Francis A., Kim, Kenneth M., Lapid, Carlo M., Castro, Marc Jerrone R., Yangzon, Maria Sofia L., Maralit, Benedict A., Ayes, Marc Edsel C., Cutiongco-de la Paz, Eva Maria, De Guzman, Alethea R., Yap, Jan Michael C. et al. · 2021
34. Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes
    Chunyan Wang, Emma L. Hesketh, Tatiana M. Shamorkina, Wentao Li, Peter J. Franken, Dubravka Drabek, Rien van Haperen, Sarah Townend, Frank J. M. van Kuppeveld, Frank G. Grosveld et al. · 2022 · Nature Communications
35. Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
    André E. Nel, Jeff F. Miller · 2021 · ACS Nano
36. Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
    Manish Chandra Choudhary, Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain, Carlee Moser, Michael D. Hughes, Justin Ritz, Ruy Miguel Ribeiro et al. · 2022 · Nature Microbiology
37. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity
    Szu‐Wei Huang, Sheng‐Fan Wang · 2021 · International Journal of Molecular Sciences
38. T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity
    Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, Rachel M. Gittelman, Jim B. Boonyaratanakornkit, Anna Wald, Stacy Selke, Mark H. Wener, Chihiro Morishima, Alexander L. Greninger et al. · 2022 · JCI Insight
39. COVID-19, the first pandemic in the post-genomic era
    Lucy van Dorp, Charlotte J. Houldcroft, Damien Richard, François Balloux · 2021 · Current Opinion in Virology
40. Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions
    Mary Hongying Cheng, James Krieger, Anupam Banerjee, Yufei Xiang, Burak Kaynak, Yi Shi, Moshe Arditi, İvet Bahar · 2022 · iScience
41. Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities
    Yaozong Chen, Lulu Sun, Irfan Ullah, Guillaume Beaudoin-Bussières, Sai Priya Anand, Andrew P. Hederman, William David Tolbert, Rebekah T. Sherburn, Dung Ngoc Pham Nguyen, Lorie Marchitto et al. · 2022 · Science Advances
42. The Genetic Variant of SARS-CoV-2: Would it matter for Controlling the Devastating Pandemic?
    Shuxin Guo, Kefang Liu, Jun Zheng · 2021 · International Journal of Biological Sciences
43. Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
    Zhuocheng Yao, Lin Zhang, Yuange Duan, Xiaolu Tang, Jian Lü · 2024 · Journal of Infection
44. Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic
    Charles Yap, Abulhassan Ali, Amogh Prabhakar, Akul Prabhakar, Aman Pal, Ying Yi Lim, Pramath Kakodkar · 2021 · Therapeutic Advances in Vaccines and Immunotherapy
45. Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview
    Rukmankesh Mehra, Kasper P. Kepp · 2021 · ACS Infectious Diseases
46. Spike protein of SARS-CoV-2 variants: a brief review and practical implications
    Kattlyn Laryssa Candido, Caio Ricardo Eich, Luciana Oliveira de Fariña, Marina Kimiko Kadowaki, José Luis da Conceição Silva, Alexandre Maller, Rita de Cássia Garcia Simão · 2022 · Brazilian Journal of Microbiology
47. Template switching and duplications in SARS-CoV-2 genomes give rise to insertion variants that merit monitoring
    Sofya K. Garushyants, Igor B. Rogozin, Eugene V. Koonin · 2021 · Communications Biology
48. The Development of SARS-CoV-2 Variants: The Gene Makes the Disease
    Raquel Pérez-Gómez · 2021 · Journal of Developmental Biology
49. Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria
    Egon Anderson Ozer, Lacy M. Simons, Moses Olubusuyi Adewumi, Adeola Fowotade, Ewean Chukwuma Omoruyi, Johnson Adekunle Adeniji, Oluseyi Adebowale Olayinka, Taylor J. Dean, Janet P. Zayas, Pavan P. Bhimalli et al. · 2022 · Nature Communications
50. The ongoing evolution of variants of concern and interest of SARS-CoV-2 in Brazil revealed by convergent indels in the amino (N)-terminal domain of the spike protein
    Paola Cristina Resende, Felipe Gomes Naveca, Roberto Dias Lins, Filipe Zimmer Dezordi, Matheus Vitor Ferreira Ferraz, Emerson Gonçalves Moreira, Danilo F. Coêlho, Fernando Couto Motta, Anna Carolina Dias Paixão, Luciana Appolinario et al. · 2021 · Virus Evolution
51. Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein
    Marco Gerdol, Klevia Dishnica, Alejandro Giorgetti · 2022 · Virus Research
52. Graphene Transistors for In Vitro Detection of Health Biomarkers
    Changhao Dai, Derong Kong, Chang Chen, Yunqi Liu, Dacheng Wei · 2023 · Advanced Functional Materials
53. High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19
    Sung Hee Ko, Elham Bayat Mokhtari, Prakriti Mudvari, Sydney R. Stein, Christopher D. Stringham, Danielle A. Wagner, Sabrina C. Ramelli, Marcos Javier Ramos-Benítez, Jeffrey R. Strich, Richard T. Davey et al. · 2021 · PLoS Pathogens
54. Comparative transcriptomic analysis of SARS-CoV-2 infected cell model systems reveals differential innate immune responses
    Guihua Sun, Qi Cui, Gustavo Garcia, Cheng Wang, Mingzi Zhang, Vaithilingaraja Arumugaswami, Arthur D. Riggs, Yanhong Shi · 2021 · Scientific Reports
55. Evolution of the SARS-CoV-2 genome and emergence of variants of concern
    Iman Safari, Elahe Elahi · 2021 · Archives of Virology
56. The past, current and future epidemiological dynamic of SARS-CoV-2
    François Balloux, Cedric C.S. Tan, Leo Swadling, Damien Richard, Charlotte Jenner, Mala K. Maini, Lucy van Dorp · 2022 · Oxford Open Immunology
57. Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution
    Yulong Song, Xiuju He, Wen‐Bin Yang, Yaoxing Wu, Jun Cui, Tian Tang, Rui Zhang · 2022 · Nucleic Acids Research
58. Insertions and Deletions (Indels): A Missing Piece of the Protein Engineering Jigsaw
    Charlotte M. Miton, Nobuhiko Tokuriki · 2022 · Biochemistry
59. A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020
    Broňa Brejová, Kristína Boršová, Viktória Hodorová, Viktória Čabanová, Lenka Reizigová, Evan David Paul, Pavol Čekan, Boris Klempa, Jozef Nosek, Tomáš Vinař · 2021 · Virus Genes
60. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
    Yusri Taha, Hayley Wardle, Adam B. Evans, Ewan Hunter, Helen J. Marr, Wendy Osborne, Matthew Bashton, Darren Smith, Shirelle Burton-Fanning, Matthias Ludwig Schmid et al. · 2021 · Annals of Clinical Microbiology and Antimicrobials
61. Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization
    Qiong Wang, Sheng‐Bao Ye, Zhijian Zhou, A‐Ling Song, Xi Zhu, Jia‐Mei Peng, Rui‐Min Liang, Chen‐Hui Yang, Xiaowei Yu, Xun Huang et al. · 2022 · Journal of Medical Virology
62. SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring
    Filipe Pereira · 2021 · Biochemical and Biophysical Research Communications
63. Animal models of SARS-CoV-2 transmission
    R. D. de Vries, B. Rockx, B. Haagmans, S. Herfst, M. Koopmans, R. D. de Swart · 2021 · Current Opinion in Virology
64. Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights
    Dorottya Nagy‐Szakal, Mara Couto-Rodriguez, Heather Wells, Joseph Barrows, Marilyne Debieu, Kristin D. Butcher, Siyuan Chen, Agnes Berki, Courteny Hager, Robert J. Boorstein et al. · 2021 · Microbiology Spectrum
65. Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
    A. Aiello, Saeid Najafi-Fard, D. Goletti · 2023 · Frontiers in Immunology
66. In War Times: Fictionalizing Iraq
    Roger Luckhurst · 2012 · Contemporary Literature
67. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19
    Joyce van de Leemput, Zhe Han · 2021 · Molecular and Cellular Biology
68. Antibodies induced by an ancestral SARS-CoV-2 strain that cross-neutralize variants from Alpha to Omicron BA.1
    Ian W. Windsor, Pei Tong, Olivia Lavidor, Ali Sanjari Moghaddam, Lindsay G. A. McKay, Avneesh Kumar Gautam, Yuezhou Chen, Elizabeth A. MacDonald, Duck Kyun Yoo, Anthony Griffths et al. · 2022 · Science Immunology
69. SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial
    Monika Tandon, Wen Wu, Keith Moore, Stephen Winchester, Yuan-Po Tu, Christopher Miller, Rahul Kodgule, Amol Pendse, Shabbir Rangwala, Shashank Joshi · 2022 · The Lancet Regional Health - Southeast Asia
70. Evolutionary remodelling of N‐terminal domain loops fine‐tunes SARS‐CoV‐2 spike
    Diego M. Cantoni, Matthew J Murray, Mphatso D. Kalemera, Samuel J. Dicken, Lenka Stejskal, Georgina Brown, Spyros Lytras, Jonathon D. Coey, James Patrick McKenna, Stephen Bridgett et al. · 2022 · EMBO Reports
71. Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2
    Samuel J. Dicken, Matthew J Murray, Lucy Thorne, Ann‐Kathrin Reuschl, Calum Forrest, Maaroothen Ganeshalingham, Luke Muir, Mphatso D. Kalemera, Machaela Palor, Laura E. McCoy et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
72. Coincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in Nigeria
    Ozer, Egon A., Simons, Lacy M., Adewumi, Olubusuyi M., Fowotade, Adeola A., Omoruyi, Ewean C., Adeniji, Johnson A., Dean, Taylor J., Zayas, Janet, Bhimalli, Pavan P., Ash, Michelle K. et al. · 2021
73. Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
    Khalid Mohamed Adam · 2021 · Tropical Diseases Travel Medicine and Vaccines
74. Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro
    Fabrizio Pucci, Marianne J. Rooman · 2021 · Viruses
75. Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System
    Joaquı́n Dopazo, Douglas Maya‐Miles, Féderico García, Nicola Lorusso, Miguel Ángel Calleja, María Jesús Pareja, José López‐Miranda, Jesús Rodríguez‐Baño, Javier Padillo, Isaac Túnez et al. · 2021 · Journal of Personalized Medicine
76. Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
    Krystallenia Paniskaki, Moritz Anft, Toni Luise Meister, Corinna Sophie Marheinecke, Stephanie Pfaender, Sarah Skrzypczyk, Felix Sebastian Seibert, Constantin J. Thieme, Margarethe Konik, Sebastian Dolff et al. · 2022 · Frontiers in Immunology
77. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
    Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, E. Binshtein, Rita E. Chen, J. Case, Kevin J. Kramer, Erica C. Armstrong, Luke Myers, Andrew Trivette et al. · 2022 · bioRxiv
78. SARS-CoV-2 and pathological matrix remodeling mediators
    Imen Guizani, Nesrine Fourti, Wiem Zidi, Moncef Feki, Monia Elasmi · 2021 · Inflammation Research
79. Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil
    Alessandra Pavan Lamarca, Luiz Gonzaga Paula de Almeida, Ronaldo da Silva Francisco, Lucymara Fassarella Agnez‐Lima, Kátia Castanho Scortecci, Vinícius Pietta Perez, Otávio J. B. Brustolini, Eduardo Sérgio Soares Sousa, Danielle Secco, Ângela Santos et al. · 2021 · PLoS neglected tropical diseases
80. Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
    Théophile Cocherie, Karen Zafilaza, Valentin Leducq, Stéphane Marot, Vincent Cálvez, Anne‐Geneviève Marcelin, Ève Todesco · 2022 · Microorganisms
81. mRNA COVID-19 Vaccines—Facts and Hypotheses on Fragmentation and Encapsulation
    Jacques Demongeot A, Cécile Fougère · 2022 · Vaccines
82. Estimating the strength of selection for new SARS-CoV-2 variants
    Christiaan Hendrik van Dorp, Emma E. Goldberg, Nicolas Hengartner, Ruian Ke, Ethan Obie Romero-Severson · 2021 · Nature Communications
83. Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins
    Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín · 2022 · International Journal of Molecular Sciences
84. The Mutational Landscape of SARS-CoV-2
    Bryan Saldivar‐Espinoza, Pol Garcia‐Segura, Nil Novau-Ferré, Guillem Macip, Rubén Martínez, Pere Puigbò, Adrià Cereto‐Massagué, Gerard Pujadas, Santiago Garcı́a-Vallvé · 2023 · International Journal of Molecular Sciences
85. Structural understanding of SARS-CoV-2 virus entry to host cells
    Kim Phuong Uyen Le, Shrute Kannappan, Truc Kim, Jung Heon Lee, Hye-Ra Lee, Kyeong Kyu Kim · 2023 · Frontiers in Molecular Biosciences
86. Evolution of Antiviral Drug Resistance in SARS-CoV-2
    Roy Dinata, Piyush Baindara, Santi M. Mandal · 2025 · Viruses
87. COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance
    Michiel J.M. Niesen, Praveen Anand, Eli Silvert, Rohit Suratekar, Colin Pawlowski, Pritha Ghosh, Patrick J. Lenehan, Travis K. Hughes, David Zemmour, John Charles O’Horo et al. · 2021 · medRxiv
88. Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution
    Ida Monrad, Signe Risgaard Sahlertz, Stine Sofie Frank Nielsen, Louise Ørnskov Pedersen, Mikkel Steen Petersen, Carl Mathias Kobel, Irene Harder Tarpgaard, Merete Storgaard, Klaus Leth Mortensen, Mariane Høgsbjerg Schleimann et al. · 2021 · Open Forum Infectious Diseases
89. Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
    Günl, Franziska, Mecate-Zambrano, Angeles, Rehländer, Selina, Hinse, Saskia, Ludwig, Stephan, Brunotte, Linda · 2021 · Vaccines
90. Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
    Graham, Carl, Seow, Jeffrey, Huettner, Isabella, Khan, Hataf, Kouphou, Neophytos, Acors, Sam, Winstone, Helena, Pickering, Suzanne, Galao, Rui Pedro, Lista, Maria Jose et al. · 2021
91. Anti-SARS-CoV-1 and −2 nanobody engineering towards avidity-inspired therapeutics
    Eugene Marfo Obeng, Christian K. O. Dzuvor, Michael K. Danquah · 2021 · Nano Today
92. “Is Omicron mild”? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies
    Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, Shweta Chand, Lata Joshi, Atika Chandra, Sadhna Babbar, Shailendra Goel, S. N. Raina, Behrouz Shiran · 2022 · Journal of Medical Virology
93. Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
    Ahmed Sayed Abdel-Moneim, Elsayed M. Abdelwhab, Ziad Ahmed Memish · 2021 · Virology
94. Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants
    Rafael Bayarri‐Olmos, Ida Jarlhelt, Laust Bruun Johnsen, Cecilie Bo Hansen, Charlotte Helgstrand, Jais Rose Bjelke, Finn Matthiesen, Susanne Dam Nielsen, Kasper Karmark Iversen, Sisse Rye Ostrowski et al. · 2021 · Frontiers in Immunology
95. Genomic diversity of SARS‐CoV‐2 in Pakistan during the fourth wave of pandemic
    Massab Umair, Aamer Ikram, Zaira Rehman, Syed Adnan Haider, Muhammad Ammar, Nazish Badar, Qasim Ali, Muhammad Suleman Rana, Muhammad Salman · 2022 · Journal of Medical Virology
96. Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells
    Pakorn Aiewsakun, Worakorn Phumiphanjarphak, Natali Ludowyke, Priyo Budi Purwono, Suwimon Manopwisedjaroen, Chanya Srisaowakarn, Supanuch Ekronarongchai, Ampa Suksatu, Jirundon Yuvaniyama, Arunee Thitithanyanont · 2023 · Genome Biology and Evolution
97. SARS-CoV-2 before and after Omicron: two different viruses and two different diseases?
    Renata Gili, Roberto Burioni · 2023 · Journal of Translational Medicine
98. Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis
    Héctor Díaz‐García, Ana Laura Guzmán-Ortiz, Tania Ángeles-Floriano, Israel Parra‐Ortega, Briceida López-Martı́nez, Mirna Martínez‐Saucedo, Guillermo Aquino‐Jarquín, Rocío Sánchez‐Urbina, Héctor Quezada, Javier Tadeo Granados-Riveron · 2021 · Genes
99. Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions
    Masaud Shah, Hyun Goo Woo · 2021 · Molecules and Cells
100. Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations
     Li Shen, Jennifer Dien Bard, Timothy Junius Triche, Alexander Russell Judkins, Jaclyn A. Biegel, Xiaowu Gai · 2021 · Emerging Microbes & Infections